1. Home
  2. VYGR vs ZVIA Comparison

VYGR vs ZVIA Comparison

Compare VYGR & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ZVIA
  • Stock Information
  • Founded
  • VYGR 2013
  • ZVIA 2007
  • Country
  • VYGR United States
  • ZVIA United States
  • Employees
  • VYGR N/A
  • ZVIA N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • VYGR Health Care
  • ZVIA Consumer Staples
  • Exchange
  • VYGR Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • VYGR 231.9M
  • ZVIA 193.4M
  • IPO Year
  • VYGR 2015
  • ZVIA 2021
  • Fundamental
  • Price
  • VYGR $4.95
  • ZVIA $2.27
  • Analyst Decision
  • VYGR Strong Buy
  • ZVIA Buy
  • Analyst Count
  • VYGR 8
  • ZVIA 4
  • Target Price
  • VYGR $16.71
  • ZVIA $4.61
  • AVG Volume (30 Days)
  • VYGR 814.4K
  • ZVIA 870.1K
  • Earning Date
  • VYGR 11-11-2025
  • ZVIA 11-05-2025
  • Dividend Yield
  • VYGR N/A
  • ZVIA N/A
  • EPS Growth
  • VYGR N/A
  • ZVIA N/A
  • EPS
  • VYGR N/A
  • ZVIA N/A
  • Revenue
  • VYGR $42,580,000.00
  • ZVIA $158,371,000.00
  • Revenue This Year
  • VYGR N/A
  • ZVIA $6.44
  • Revenue Next Year
  • VYGR $107.10
  • ZVIA $6.68
  • P/E Ratio
  • VYGR N/A
  • ZVIA N/A
  • Revenue Growth
  • VYGR N/A
  • ZVIA N/A
  • 52 Week Low
  • VYGR $2.65
  • ZVIA $0.96
  • 52 Week High
  • VYGR $8.28
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 58.14
  • ZVIA 39.46
  • Support Level
  • VYGR $4.72
  • ZVIA $2.24
  • Resistance Level
  • VYGR $5.55
  • ZVIA $2.57
  • Average True Range (ATR)
  • VYGR 0.35
  • ZVIA 0.15
  • MACD
  • VYGR -0.01
  • ZVIA 0.01
  • Stochastic Oscillator
  • VYGR 54.88
  • ZVIA 15.45

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: